Department of Internal Medicine, Seoul National University Hospital, Seongnam, Republic of Korea.
Am J Nephrol. 2013;37(1):74-83. doi: 10.1159/000345960. Epub 2013 Jan 22.
Previous epidemiological studies have focused on the prevalence of primary glomerulonephritis (GN), but few have explored long-term patient outcomes. This study was conducted to investigate the long-term patient and renal outcomes of primary GN.
A total of 1,943 biopsy-proven primary GN patients were included. The outcomes were mortality and end-stage renal disease (ESRD) progression. The relative mortality rate was expressed by the standardized mortality ratio (SMR) and the 95% confidence interval (CI).
During the median follow-up of 90 months, 325 (16.7%) patients progressed to ESRD and 164 (8.4%) patients died. Patients with minimal change disease exhibited the best renal and patient outcomes, whereas those with membranoproliferative GN had the worst. IgA nephropathy patients appeared to have a good survival rate in spite of their considerable progression to ESRD, and focal segmental glomerulosclerosis patients showed poor renal and patient outcomes. Mortality was 67% higher in primary GN patients than in the age- and sex-matched general population (SMR, 1.67; 95% CI, 1.42-1.95). The difference was more prominent in women (SMR, 2.95; 95% CI, 2.27-3.77) than in men (SMR, 1.31; 95% CI, 1.07-1.60). Renal risk factors, e.g. hypertension, proteinuria and initial renal dysfunction, were all associated with higher mortality, and the relative mortality rate increased with the number of risk factors.
In patients with primary GN, mortality is significantly higher than in the age-/sex-matched general population, especially in women. Moreover, the presence of renal risk factors is positively associated with both relative mortality and progression to ESRD.
先前的流行病学研究集中于原发性肾小球肾炎(GN)的患病率,但很少有研究探索长期患者结局。本研究旨在调查原发性 GN 的长期患者和肾脏结局。
共纳入 1943 例经活检证实的原发性 GN 患者。结局为死亡率和终末期肾脏疾病(ESRD)进展。相对死亡率用标准化死亡率比(SMR)及其 95%置信区间(CI)表示。
在中位 90 个月的随访期间,325 例(16.7%)患者进展为 ESRD,164 例(8.4%)患者死亡。微小病变病患者的肾脏和患者结局最好,而膜增生性 GN 患者最差。尽管 IgA 肾病患者大量进展为 ESRD,但似乎具有良好的生存率,局灶节段性肾小球硬化患者的肾脏和患者结局较差。原发性 GN 患者的死亡率比年龄和性别匹配的一般人群高 67%(SMR,1.67;95%CI,1.42-1.95)。女性的差异更为显著(SMR,2.95;95%CI,2.27-3.77),而男性的差异较小(SMR,1.31;95%CI,1.07-1.60)。肾脏危险因素,如高血压、蛋白尿和初始肾功能障碍,均与较高的死亡率相关,且相对死亡率随危险因素数量的增加而增加。
在原发性 GN 患者中,死亡率明显高于年龄/性别匹配的一般人群,尤其是女性。此外,肾脏危险因素的存在与相对死亡率和进展为 ESRD 均呈正相关。